AGAPE ATP CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
AGAPE ATP CORPORATION (ATPC) reported Cash and Cash Equivalents, Period Increase (Decrease) of $307.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-13
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $307.00K.
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$582.81K.
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $2.26M.
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$299.56K.
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.22M, a 47.31% decline from fiscal 2017.
- AGAPE ATP CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.31M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-09-30 | $307.00K 10-Q · filed 2018-11-13 | -$275.80K derived: sum of 2 quarters · filed 2018-11-13 | $1.98M derived: sum of 3 quarters · filed 2018-11-13 | $1.68M derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-06-30 | -$582.81K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-09-27 | $1.67M derived: sum of 2 quarters · filed 2018-09-27 | $1.37M derived: sum of 3 quarters · filed 2018-09-27 | $1.22M 10-K · filed 2018-09-27 |
| 2018-03-31 | $2.26M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2018-06-19 | $1.96M derived: sum of 2 quarters · filed 2018-06-19 | $1.80M 10-Q/A · filed 2018-06-19 | |
| 2017-12-31 | -$299.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-13 | -$454.59K 10-Q · filed 2018-02-13 | ||
| 2017-09-30 | -$155.03K 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $2.31M 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |